✓Strengths
- Return on equity is healthy at 49.6%.
- Net profit margin is strong at 95.8%.
!Watch-points
- Higher leverage: debt-to-equity of 1.95 is above 1.
- Thin interest cover: operating profit covers interest only about -6.6 times.
- Return on capital employed is on the lower side at -19.5%.
- Profit growth has been slow over five years (about -18% a year).
- Sales growth has been slow over five years (about -18% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.31
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreModerate
5 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 798.83
ROCE-19.45%
ROE49.55%
Debt to Equity1.95
Current Ratio1.39
EPS₩ 396.00
PAT Margin95.84%
ICR-6.57
Compounded Sales Growth
10 Years
—
5 Years
-17.51%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
-18.32%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
49.55%